Literature DB >> 2230140

A comparison of immunoblotting, flow cytometry and ELISA to monitor the binding of anti-lipopolysaccharide monoclonal antibodies.

D Nelson1, W Neill, I R Poxton.   

Abstract

This study was designed to assess the use of flow cytometry to observe the binding, under physiological conditions, of anti-lipopolysaccharide (LPS) monoclonal antibodies (mAbs) to whole bacteria, and to compare this with the more conventional whole cell ELISA and immunoblotting techniques. The bacteria consisted of two clinical isolates of E. coli 018:K1 and 06:K5 and two isogenic mutants of the 018 parent: a non-capsulate (018:K-) and a rough mutant (018rf). Two cross-reactive anti-core mAbs and one 018 0-antigen-specific mAb were used. ELISA and flow cytometry showed that capsule and O-polysaccharide influenced the binding of mAbs to the bacteria, whilst the latter technique demonstrated that sub-populations existed. Immunoblotting showed the two anti-core mAbs to be different, one bound only to core which was not substituted with O-antigen, whilst the other bound both to substituted and unsubstituted core. This comparison for monitoring the binding of anti-LPS mAbs demonstrates the potential use of flow cytometry in bacterial cell surface research, and complements results obtained by ELISA and immunoblotting.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2230140     DOI: 10.1016/0022-1759(90)90363-z

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Loss of regulatory protein RfaH attenuates virulence of uropathogenic Escherichia coli.

Authors:  Gábor Nagy; Ulrich Dobrindt; György Schneider; A Salam Khan; Jörg Hacker; Levente Emödy
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Oral immunization with an rfaH mutant elicits protection against salmonellosis in mice.

Authors:  Gábor Nagy; Ulrich Dobrindt; Jörg Hacker; Levente Emödy
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

3.  Diagnostic potential of monoclonal antibodies specific to the unique O-antigen of multidrug-resistant epidemic Escherichia coli clone ST131-O25b:H4.

Authors:  Valéria Szijártó; Jolanta Lukasiewicz; Tomasz K Gozdziewicz; Zoltán Magyarics; Eszter Nagy; Gábor Nagy
Journal:  Clin Vaccine Immunol       Date:  2014-04-30

4.  Down-regulation of key virulence factors makes the Salmonella enterica serovar Typhimurium rfaH mutant a promising live-attenuated vaccine candidate.

Authors:  Gábor Nagy; Vittoria Danino; Ulrich Dobrindt; Mark Pallen; Roy Chaudhuri; Levente Emödy; Jay C Hinton; Jörg Hacker
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

5.  Preparation and preclinical evaluation of a novel liposomal complete-core lipopolysaccharide vaccine.

Authors:  E Bennett-Guerrero; T J McIntosh; G R Barclay; D S Snyder; R J Gibbs; M G Mythen; I R Poxton
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

6.  Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice.

Authors:  H Frasa; B Benaissa-Trouw; L Tavares; K van Kessel; M Poppelier; K Kraaijeveld; J Verhoef
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

7.  O-Polysaccharide epitopic heterogeneity at the surface of Brucella spp. studied by enzyme-linked immunosorbent assay and flow cytometry.

Authors:  A Cloeckaert; V Weynants; J Godfroid; J M Verger; M Grayon; M S Zygmunt
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

8.  Helicobacter pylori lipopolysaccharide modification, Lewis antigen expression, and gastric colonization are cholesterol-dependent.

Authors:  Ellen Hildebrandt; David J McGee
Journal:  BMC Microbiol       Date:  2009-12-14       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.